HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Capital World Limited: 4Q2025 Earnings

Capital World Limited reported a net loss for the full year, though its loss...
SGX-LISTED COMPANIES

Lincotrade & Associates Holdings Limited: FY2025 Financial Announcement

Lincotrade's latest financial announcement highlights a period of significant growth and strategic reorientation. The...
SGX-LISTED COMPANIES

British & Malayan Holdings Limited: Full Year Financials and Dividend, June 2025

The Group achieved a reduced net loss this year, driven by higher trustee service...
SGX-LISTED COMPANIES

ASL Marine Holdings: FY2025 Financial Results

ASL Marine Holdings Ltd. announces positive financial results for the year ended 30 June...
SGX-LISTED COMPANIES

GuocoLand Limited: FY2025 Financial Results and Outlook

GuocoLand Limited FY2025 reflects a robust Singapore property market, fueled by strong demand and...
SGX-LISTED COMPANIES

iX Biopharma’s Robust FY2025 Performance and Strategic Outlook

iX Biopharma LTD achieved robust financial performance with significant revenue and gross profit growth,...
SGX-LISTED COMPANIES

Oxley Holdings Strategic Repositioning and FY2025 Performance

Oxley Holdings Limited is undergoing a significant strategic transformation, narrowing its focus to core...
SGX-LISTED COMPANIES

Sakae Holdings: Financial Results 30 June 2025

Sakae Holdings LTD navigated a challenging F&B landscape, facing increased operating costs and cautious...
SGX-LISTED COMPANIES

Lum Chang Holdings Limited: FY2025 Interim Financial Statements

Lum Chang Holdings Limited saw an improved financial year, with better profitability and margins....
SGX-LISTED COMPANIES

Thomson Medical Group’s FY2025: Strategic Growth and Johor Bay Development

Thomson Medical Group's recent financial period reflects a deliberate investment strategy for future growth,...
SGX-LISTED COMPANIES

Aedge Group: FY2025 Financial Results and Operational Outlook

Aedge Group Limited faced increased losses in the past financial year, yet strategic growth...
SGX-LISTED COMPANIES

Micro-Mechanics: FY2025 Profit Growth and Strategic Initiatives

Micro-Mechanics reports a period of robust performance, fuelled by the successful implementation of its...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...